FDA to Hold Hearing on Proposed Withdrawal of Generic ADHD Medication Approval

The FDA has approved a request for a hearing regarding a proposal to revoke the approval for Kremers Urban Pharmaceuticals' generic version of Concerta. This decision concerns a central nervous system stimulant used to treat ADHD, indicating a regulatory review of its market status.